Expanding shared stay-in eldercare services, help with fertility treatments among MOH measures
Sign up now: Get ST's newsletters delivered to your inbox
Services where a live-in caregiver takes care of several seniors in a single apartment will be made a mainstream option.
PHOTO: LIANHE ZAOBAO FILE
Follow topic:
SINGAPORE – Greater support for certain fertility treatments, more eldercare options and enhanced subsidies for more drugs under Healthier SG are some of the government initiatives for which the Ministry of Health (MOH) provided updates on March 7.
Making shared stay-in senior care services widely available
As family sizes shrink and more senior-care options are needed, services where a live-in caregiver takes care of several seniors in a single apartment will be made a mainstream option.
This comes after a trial of such eldercare services,
More than 200 seniors have enrolled in the service since then, said Second Minister for Health Masagos Zulkifli in Parliament on March 7, responding to questions from Ms Ng Ling Ling (Ang Mo Kio GRC) and Mr Yip Hon Weng (Yio Chu Kang).
Companies that took part in the trial were afforded certain work-pass flexibilities – such as additional foreign worker quota and more options to hire from other countries – to help determine sustainable deployment of manpower to cater to the needs of seniors around the clock.
MOH said it had received positive feedback regarding the trial from providers, as well as seniors and their next-of-kin, and would thus make the service mainstream with the support of the Manpower Ministry and the Agency for Integrated Care.
Work-pass flexibilities will be extended to firms intending to provide such services, MOH said.
“This service will not be licensed as it provides caregiving support similar to how family members would care for their loved ones at home,” said Mr Masagos, adding that all companies willing to work with the authorities on similar innovative care models to support ageing in place are welcome to do so.
Application details and a guide detailing recommended practices when providing or seeking such services will be made available to companies from the second half of 2025.
Improving financial support for fertility preservation procedures
From June, up to 80 per cent in means-tested subsidies will be extended to embryo-, egg- and sperm-freezing procedures for those who want to be parents but face irreversible infertility because of treatments such as chemotherapy and radiotherapy.
Means-testing uses criteria such as per capita household income to ensure subsidies go to those who need them more.
And from June 2026, MediShield Life coverage will also be extended to embryo and egg freezing, while MediSave will be extended to all components of embryo freezing, including costs before and after the procedure.
Ovarian tissue freezing, which is already eligible for up to 80 per cent of means-tested subsidies, will also have MediShield Life and MediSave coverage extended to cover it from June 2026.
“Those who still face challenges with the cost of their fertility preservation treatments arising from medically necessary treatments may also approach medical social workers at their public healthcare institutions for further assistance, including to apply for MediFund,” said Minister of State for Health Rahayu Mahzam, announcing the measures in Parliament.
“With these changes, we hope to assure patients facing medical challenges that their dreams of starting a family in the future are still within reach,” she added.
Three more drugs eligible for enhanced subsidies under Healthier SG Chronic Tier
Three more drugs will be eligible for means-tested subsidies of up to 87.5 per cent under the Healthier SG Chronic Tier, which offers enhanced subsidies on selected chronic medications at general practice clinics under the national preventive health initiative.
The drugs include evolocumab, an immunotherapy medication used to treat some people who have high cholesterol levels despite being on other cholesterol lowering medications, as well as those with familial hypercholesterolemia, a genetic disorder characterised by high cholesterol levels.
The other two treatments eligible for enhanced subsidies are Humalog Mix25 and Humalog Mix50 Kwikpens, insulins used for blood sugar control in patients with Type 1 or Type 2 diabetes.
With the enhanced subsidies evolocumab – which now costs more than $230 per month – would cost between $30 and $60 monthly, depending on the patient’s age and means-test status.
As the country’s primary care system advances, the Government will ensure that people can access affordable care, including drugs for chronic conditions, said Senior Minister of State for Health Janil Puthucheary.
“We will continually review the expansion of the range of medications which are subsidised under the Healthier SG Chronic Tier,” said Dr Janil.
Reducing salt and sugar consumption
Efforts to reduce sugar and sodium consumption in the Republic are bearing fruit, with the Nutri-Grade labelling scheme
Meanwhile, the “ siu dai (less sweet) by default” movement,
About six in 10 beverage chains are serving drinks with less sugar by default, MOH said.
The ministry said it will take a collaborative approach with the Health Promotion Board to encourage the use of lower-sodium ingredients and make them more widely available.
More than 1,700 eateries have switched to lower-sodium ingredients as at December 2024, compared with 500 in 2022.
MOH added that details of the expansion of the Nutri-Grade labelling and advertising measures to products high in sodium and saturated fat – such as pre-packed salt, sauces and seasonings, instant noodles and cooking oil – will be announced later this year.
Responding to Ms Ng Ling Ling (Ang Mo Kio GRC), Ms Rahayu said there were no plans to extend the Nutri-Grade scheme to dishes served in eateries for now due to the challenges in tackling sodium and saturated fat content in such an environment.
